Navigation Links
Cholesterol Drug Fails to Slow Progression of Coronary Disease,,Cleveland Clinic Study Reports

NEW ORLEANS, March 26, 2007 /PRNewswire/ -- Cleveland Clinic researchers today report that the drug torcetrapib, despite raising high density lipoprotein cholesterol (HDL) or the "good" cholesterol by more than 60%, did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe.

Steven Nissen, M.D., Chairman of Cardiovascular Medicine at Cleveland Clinic and lead investigator of this clinical trial, will present the study on Monday, March 26 at 8:30 a.m. at the of Cardiology's (ACC) 56th Annual Scientific Session. Dr. Nissen is also President of the ACC. The study will be simultaneously published in the New England Journal of Medicine.

All development of this drug was terminated on Dec. 2, 2006 after the safety board monitoring a separate large clinical outcomes trial reported that torcetrapib increased the risk of death and other adverse cardiovascular outcomes.

"We found that the torcetrabip/atorvastatin combination markedly increased good cholesterol levels and lowered bad cholesterol in patients. Unfortunately this drug also substantially raised blood pressure and failed to slow the buildup of plaque," Dr. Nissen said. "It is yet to be determined of this failure represents a problem unique to torcetrapib or predicts a lack of efficacy for the entire class of similar drugs. These findings further demonstrate the great difficulty in developing therapies to disrupt the atherosclerotic disease process."

The development of drugs to raise HDL has been a key research priority because, despite lowering LDL (low-density lipoprotein, or "bad") cholesterol with statin drugs, many patients continue to experience heart attacks, stroke or sudden cardiac death.

A total of 1,188 coronary artery disease patients were enrolled in the "Investigation of Lipid Level management using coronary UltraSound To assess Reduction of Atherosclerosis by CET
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
4. KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
5. CSL Therapy That Mimics “Good” Cholesterol May Reduce Plaque Volume in Coronary Arteries
6. CSL Therapy That Mimics Good Cholesterol May Reduce Plaque Volume in Coronary Arteries
7. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
8. Caelyx Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer
9. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published

Post Your Comments:
(Date:11/6/2009)...all/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), ... of small-molecule therapeutics for the treatment ...HIV), today reported recent accomplishments and fi...ths ended September 30, 2009. ,, (Logo: http... ) ,, "Since our last quarterly update, we have...
(Date:11/6/2009)... Chimerix, Inc., a biopharmaceutic...erapeutics to address life-threatening diseases, p...,s lead antiviral compound, CMX001, to the World H...urity Initiative (GHSI). CMX001 is a broad-spectr...nt of smallpox, as well as other serious viral inf...
(Date:11/6/2009)...l/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX...biopharmaceutical company developing human vaccine...ency Virus) and other infectious agents, today ann...d provided an operational update. ,, Robert McN... commented, "We are pleased with our progress duri...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 1Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster 12804 2HIV Testing Day Set for Saturday in U S 50162 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 1Bausch 26 Lomb Kicks Off U S Consumer Online Marketing Campaign for SofLens 28R 29 Daily Disposable Contact Lenses 50158 2
...n-Probe Incorporated,(Nasdaq: GPRO ) has submitte... supplemental regulatory application for the addit...reen donated blood for the hepatitis B,virus (HBV)...e assay to,screen donated blood for HIV-1 and the ...y is seeking approval to use the assay to screen f...
...1 Alfacell Corporation,(Nasdaq: ACEL ) today ann...,the 5th Cancer Drug Research & Development confer...ys impacted by ONCONASE stimulated,intracellular e... malignant,mesothelioma cell lines. Data presented...ll human cancer cells in cell culture and murine m...
Other Medicine Technology:Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 2Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 3Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay 4Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 2Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R) 3
(Date:11/8/2009)..., Critical legislation would strengthen Medicare...RK, Nov. 8 SUMMARY: Y...s passed critical health care reform legislation t...discrimination by insurance companies that prices ...erage. ,, The Affordable Health Care for Amer...
(Date:11/8/2009)...oring pain now can take you out of the game later,...ay News) -- Foot injuries are the talk of the NFL ...Eli Manning and running back Willie Parker. , O...tion and American Academy of Podiatric Sports Medi...et when they play fall sports like football and la...
(Date:11/8/2009)... 3D Global Solutions is plea...gram managing the proposal effort for ReSound who ...Digital Hearing Aid contract. The award includes n...Department of Defense and other federal agencies. ...vember 8, 2009 -- 3D Global Solutions is pleased t...
(Date:11/8/2009)..., "One victory does not mean the battle is won,"... 7 In a vote of 240-194...inski-Smith Amendment to prohibit abortion mandate.... ,, Americans United for Life Action President... this amendment is a victory for the pro-life Amer...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 T...Director, Operation Rescue Insurrecta Nex. ,, ...ry have been fighting to keep child-killing by abo..., Mr. Terry states: "This is a great first step to...t we have a lot of fighting ahead of us. Our rejoi...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...uspected SARS case in six months may have the coro... it was waiting for more results to come in.// ... contracted the SARS coronavirus," Xu Ruiheng, dep...g. A 32-year-old television worker is suspe...
... than 5 million service men and women before and a...reducing an alarmingly high rate of suicide seen a...had been particularly higher for black and white m...osocial problems, with an emphasis on removing the...
...elief that infants' brains don't divide into left-...tudy finds the brain's left hemisphere plays the l...s beginning almost immediately after birth. Re...ime fMRI has been used to study infants. It is a n...
...archers say common cold may help fight cancer. Re...neer the common cold virus so that //it kills canc... They did this by modifying one gene, so the virus.... Specialists say, “When the virus infects cells, ...
...hma have long recommended inhaled corticosteroid (... persistent forms of the condition.But reports abo...ple -- including parents of asthmatic children -- ...problems. Now leading scientists hope to put t...
...peutic option for patients with complicated type 1...e has been controversial. // Now, a new study f...pear to have worse survival than patients on the t... had or need a kidney transplant. However, in the ...
Other Medicine News:Health News:New Technique to Study Infants Brain. 2Health News:Benefits and Risks of Asthma Treatment Questioned 2Health News:Pancreas Transplant for Diabetics 2
TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
Wiseguide Guide Catheter
Convoy Catheter Introducer Sheaths
...-Cath, Maximum, Maximum Xtra, and Maximum ACT intr... specialty hemostasis introducers in the world. Th...ucers for use in interventional cardiology and ele...ngioplasty, stenting, atherectomy, temporary pacin...
Medicine Products: